| 1 | Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melhem M, Duncan H, Heffelfinger SC : Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 21:99-110, 2003 |
| 2 | Wong AP, Nili N, Strauss BH :In vitro differences between venous and arterial-derived smooth muscle cells: potential modulatory role of decorin. Cardiovasc Res65:702-710, 2005 |
| 3 | Rectenwald JE, Pretus HA, Seeger JM, Huber TS, Mendenhall NP, Zlotecki RA, Palta JR, Li ZF, Hook SY, Sarac TP, Welborn MB, Klingman NV, Abouhamze ZS, Ozaki CK: External-beam radiation therapy for improved dialysis access patency: feasibility and early safety. Radiat Res 156:53-60, 2001 |
| 4 | Kim SJ, Masaki T, Rowley R, Leypoldt JK, Mohammad SF, Cheung AK: Different responses by cultured aortic and venous smooth muscle cells to gamma radiation. Kidney Int 68:371-377, 2005 |
| 5 | Fuster V, Charlton P, Boyd A: Clinical protocol. A phase Ilb, randomized, multicenter, doubleblind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. Hum Gene Ther 12:2025-2027, 2001 |
| 6 | Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(Suppl 3): S112-119, 1998 |
| 7 | Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL: Interlenkin-f predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114. 1998 ScienceOn |
| 8 | Zimmermann J. Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 556:648-658, 1999 |
| 9 | Beathard GA, Arnold P, Jackson J, Litchfield T, and physician operators forum of RMS lifeline: Aggressive treatment of early fistula failure. Kidney Int 64:1487-1494, 2003 |
| 10 | Masaki T, Kamerath CD, Kim SJ, Leypoldt JK, Mohammad SF, Cheung AK: In vitro pharmacological inhibition of human vascular smooth muscle cell proliferation for the prevention of hemodialysis vascular access stenosis. Blood Purif 22:307-312, 2004 |
| 11 | Schindler R: Causes and therapy of microinflammation in renal failure. Nephrol Dial Transplant 9(Suppl 5):v34-40, 2004 |
| 12 | Aldenhoff YB, van Der Veen FH, ter Woorst J. Habets J, Poole-Warren LA, Koole LH: Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res 54: 224-233, 2001 |
| 13 | Rey J. Probst H, Mazzolai L, Bosman FT, Pusztaszeri M, Stergiopulos N, Ris HB, Hayoz D, Saucy F, Corpataux JM: Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein. J Surg Res 121:42-49, 2004 |
| 14 | Rekhter M, Nicholls S, Ferguson M, Gordon D: Cell proliferation in human arteriovenous fistulae used for hemodialysis. Arterioscler Thromb 13: 609-617, 1993 |
| 15 | Kim SJ, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung AK: Arterial and venous smooth-muscle cells differ m their responses to antiproliferative drugs. J Lab Clin Med 144:156-162, 2004 |
| 16 | Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48(Suppl 1):S176-247, 2006 ScienceOn |
| 17 | Wang Z, Castresana MR, Detmer K, Newman WH : An IkappaB-alpha mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res 102: 198-206, 2002 |
| 18 | Shik J, Parfrey PS : The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens 14:550-557, 2005 |
| 19 | Smith TP, Alshafie TA, Cruz CP, Fan CY, Brown AT, Wang Y, Eidt JF, Moursi MM: Saratin, an inhibitor of collagen-platelet interaction, decreases venous anastomotic intimal hyperplasia in a canine dialysis access model. Vase Endovascular Surg 37:259-269, 2003 |
| 20 | Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of micro inflammation in haemodialysis patients. Nephrol Dial Transplant 19:150-157, 2004 |
| 21 | Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80: 1726-1736, 1989 ScienceOn |
| 22 | Li L, Blumenthal DK, Masaki T, Terry CM, Cheung AK: Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J Cell Biochem. 2006 출판예정 |
| 23 | Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH : Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty : implication in prevention of restenosis. Am J Kidney Dis 43:74-84, 2004 ScienceOn |
| 24 | Goldman J, Zhong L, Liu SQ: Degradation of alpha-actin filaments in venous smooth muscle cells in response to mechanical stretch. Am J Physiol Heart Circ Physiol 284:H1839-1847, 2003 |
| 25 | Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002 ScienceOn |
| 26 | Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275:1089-1092, 1966 ScienceOn |
| 27 | Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305-316, 2002 |
| 28 | Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, Li L, Zhuplatov S, Chirananthavat T, Kim SJ, Kern S, Holman J, Kim SW, Cheung AK: Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int 66: 2061-2069, 2004 |
| 29 | Sun S, Beitler JJ, Ohki T, Calderon TM, Schechner R, Yaparpalvi R, Berman JW, Tellis VA, Greenstein SM: Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula. J Surg Res 115:200-208, 2003 |
| 30 | Diskin CJ: Pharmacologic intervention to prevent hemodialysis vascular access thrombosis: the next generation of treatment? Kidney Int 67: 2505, 2005 |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
